{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T08:14:28Z","timestamp":1780992868065,"version":"3.54.1"},"reference-count":12,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Reports"],"accepted":{"date-parts":[[2015,3,27]]},"abstract":"<jats:p>Imatinib mesylate is used in the treatment of chronic myeloid leukaemia, among other conditions. Oral mucosal pigmentation as a side effect is rare. We present a summary of the current literature and a case report of a 58-year-old Caucasian woman who presented with a diffuse blue-grey pigmentation of the palatal mucosa, thought to be related to long-term use of imatinib mesylate.<\/jats:p>","DOI":"10.1136\/bcr-2015-209335","type":"journal-article","created":{"date-parts":[[2015,4,16]],"date-time":"2015-04-16T14:14:04Z","timestamp":1429193644000},"page":"bcr2015209335","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":18,"title":["Mucosal pigmentation of the hard palate in a patient taking imatinib"],"prefix":"10.1136","volume":"2015","author":[{"given":"Alexandra","family":"Lyne","sequence":"first","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, Ashford and St Peter's Hospitals, Surrey, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Creedon","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, Ashford and St Peter's Hospitals, Surrey, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basil Malcolm West","family":"Bailey","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, Ashford and St Peter's Hospitals, Surrey, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2015,4,16]]},"reference":[{"key":"2025082800504077000_2015.apr16_1.bcr2015209335.1","unstructured":"National Institute for Health and Care Excellence. Guidance on the use of imatinib for chronic myeloid leukaemia, TA70. London: NICE, 2012."},{"key":"2025082800504077000_2015.apr16_1.bcr2015209335.2","unstructured":"Novartis Pharmaceuticals Corporation. Gleevec (Imatinib Mesylate) Prescribing Information. East Hanover, New Jersey: Novartis, 2014."},{"key":"2025082800504077000_2015.apr16_1.bcr2015209335.3","doi-asserted-by":"publisher","DOI":"10.1007\/s12105-011-0325-4"},{"key":"2025082800504077000_2015.apr16_1.bcr2015209335.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcms.2011.07.010"},{"key":"2025082800504077000_2015.apr16_1.bcr2015209335.5","first-page":"24","article-title":"Diffuse pigmentation of the palate","volume":"100","author":"Lewis","year":"2009","journal-title":"J Okla Dent Assoc"},{"key":"2025082800504077000_2015.apr16_1.bcr2015209335.6","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1016\/j.tripleo.2010.11.006","article-title":"Oral pigmentation in the hard palate associated with imatinib mesylate therapy: a report of three cases","volume":"111","author":"Mattsson","year":"2011","journal-title":"Oral Surg Oral Med Oral Path Oral Radiol Endod"},{"key":"2025082800504077000_2015.apr16_1.bcr2015209335.7","doi-asserted-by":"crossref","first-page":"532","DOI":"10.5021\/ad.2014.26.4.532","article-title":"Imatinib mesylate-induced hyperpigmentation of the nose and palate","volume":"6","author":"Song","year":"2014","journal-title":"Ann Dermatol"},{"key":"2025082800504077000_2015.apr16_1.bcr2015209335.8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2008.02706.x"},{"key":"2025082800504077000_2015.apr16_1.bcr2015209335.9","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5070\/D3498194BX","article-title":"Oral melanosis after tyrosine kinase inhibition with imatinib for chronic myelogenous leukemia: report of a case and review of the literature","volume":"17","author":"Wong","year":"2011","journal-title":"Dermatol Online J"},{"key":"2025082800504077000_2015.apr16_1.bcr2015209335.10","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0b013e318033a76c"},{"key":"2025082800504077000_2015.apr16_1.bcr2015209335.11","first-page":"682","article-title":"Pigmented lesions of the oral cavity: review, differential diagnosis, and case presentations","volume":"70","author":"Kauzman","year":"2004","journal-title":"J Can Dent Assoc"},{"key":"2025082800504077000_2015.apr16_1.bcr2015209335.12","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdh068"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2015-209335","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T07:50:50Z","timestamp":1756367450000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2015-209335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,16]]},"references-count":12,"alternative-id":["10.1136\/bcr-2015-209335"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2015-209335","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,16]]}}}